1. Sodium Dichloroacetate Pharmacological Effect as Related to Na–K–2Cl Cotransporter Inhibition in Rats
    Jūratė Stanevičiūtė et al, 2018, Dose-Response CrossRef
  2. Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: An update of a systematic literature review
    Samantha Goodman et al, 2022, Mutation Research/Reviews in Mutation Research CrossRef
  3. Evaluation of combination protocols of the chemotherapeutic agent FX-9 with azacitidine, dichloroacetic acid, doxorubicin or carboplatin on prostate carcinoma cell lines
    Franziska Weiner et al, 2021, PLOS ONE CrossRef
  4. Isoquinolinamine FX-9 Exhibits Anti-Mitotic Activity in Human and Canine Prostate Carcinoma Cell Lines
    Jan Torben Schille et al, 2019, International Journal of Molecular Sciences CrossRef
  5. An Overview of Current Alternative Models for Use in the Context of Prostate Cancer Research
    Elisabete Nascimento-Gonçalves et al, 2020, Alternatives to Laboratory Animals CrossRef
  6. The Dog as a Model to Study the Tumor Microenvironment
    Maria I. Carvalho et al, 2021, Tumor Microenvironment CrossRef
  7. Aberrant expression of microRNAs and the miR‐1/MET pathway in canine hepatocellular carcinoma
    Y.‐C. Lai et al, 2018, Veterinary and Comparative Oncology CrossRef
  8. Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis
    Eva-Maria Packeiser et al, 2020, PLOS ONE CrossRef
  9. Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer
    Caroline E. Nunes-Xavier et al, 2022, Frontiers in Oncology CrossRef
  10. Carbohydrate metabolism in prostate cancer
    Tomas Koltai et al, 2021, Prostate Cancer Metabolism CrossRef
  11. Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a bladder cancer cell line
    Katharina Klose et al, 2021, PLOS ONE CrossRef
  12. Pharmacological interventions part IV: Metabolic modifiers
    Tomas Koltai et al, 2020, An Innovative Approach to Understanding and Treating Cancer: Targeting pH CrossRef
  13. RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures
    Eva-Maria Packeiser et al, 2022, Cancer Cell International CrossRef
  14. MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities
    Abraham Pedroza-Torres et al, 2019, Frontiers in Oncology CrossRef
  15. Investigation of serum survivin in dogs suffering from cancer: a multicenter study
    Annkathrin Estaller et al, 2021, Journal of Veterinary Science CrossRef
  16. Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines
    Katharina Klose et al, 2022, Veterinary and Comparative Oncology CrossRef
  17. Dichloroacetate affects proliferation but not apoptosis in canine mammary cell lines
    Tatjana P. Harting et al, 2017, PLOS ONE CrossRef
  18. Effects of the Latex of Synadenium grantii Hook F. (Euphorbiaceae) on a Preclinical Model of Canine Prostate Cancer
    Eric Saymom Andrade Brito et al, 2021, Frontiers in Veterinary Science CrossRef
  19. Updates on the Pivotal Roles of Mitochondria in Urothelial Carcinoma
    Chiang-Chi Huang et al, 2022, Biomedicines CrossRef